Published

Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology
Date: 2023-10-01
Source: PubMed
DOI: 10.1038/s41386-023-01607-2
PubMed: 37231080

Authors

Ley L Holze F Arikci D Becker AM Straumann I Klaiber A Coviello F Dierbach S Thomann J Duthaler U Luethi D Varghese N Eckert A Liechti ME

Watch author

Derived topics and classifications

psilocybin Pharmacology Consciousness Healthy Volunteers Safety Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 7 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participants2026-07-01 Psilocin glucuronide in whole blood: a stable and useful biomarker of psilocybin intake2026-05-23 Synthesis and Characterization of Psilocybin Metabolites and Deuterated Analogs2026-03-18 Development of a PBPK model of psilocybin/psilocin from Psilocybe cubensis (magic mushroom) in mice, rats, and humans2025-04-21 Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc Analysis2025-01-01 In vitro and in vivo metabolism of psilocybin’s active metabolite psilocin2024-04-29 Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.2023-10-01

Related papers

Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06 Comparative Acute Effects of LSD, Psilocybin and Mescaline in a Random-Order Placebo-Controlled Cross-Over Study in Healthy SubjectsClinicalTrials.gov · 2024-01-24 Role of the Serotonin 5-HT2A Receptor in Mescaline-induced Altered States of ConsciousnessClinicalTrials.gov · 2023-03-29